![Ian Alexander Francis Miscampbell](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ian Alexander Francis Miscampbell
Vorsitzender bei
Leucid Bio Ltd.
Profil
Ian Alexander Francis Miscampbell is currently the Chairman of Leucid Bio Ltd. and a Director of Adorx Therapeutics Ltd. He is also the Managing Partner of Sixth Element Capital LLP since 2011.
In the past, he worked as the Finance Director of Witham Contract Manufacturing Ltd. in 2007-2008, Director of Crawford Healthcare Ltd. in 2009, and Chief Financial Officer of York Pharma Plc, Microscience Ltd., and Oxford Immunotec Ltd.
Aktive Positionen von Ian Alexander Francis Miscampbell
| Unternehmen | Position | Beginn |
|---|---|---|
Sixth Element Capital LLP
 Sixth Element Capital LLP Investment ManagersFinance Sixth Element Capital invests in cancer and oncology drug discovery research projects across Europe. The firm provides financing for growth capital requirements with an investment up to £50 million. | Private Equity Investor | 01.08.2011 |
Adorx Therapeutics Ltd.
 Adorx Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research of new therapeutics for cancer based on modulation of the adenosine pathway | Direktor/Vorstandsmitglied | - |
Leucid Bio Ltd.
 Leucid Bio Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biotech company that develops next generation CAR-T therapy | Vorsitzender | - |
Ehemalige bekannte Positionen von Ian Alexander Francis Miscampbell
| Unternehmen | Position | Ende |
|---|---|---|
Crawford Healthcare Ltd.
 Crawford Healthcare Ltd. Medical DistributorsDistribution Services Distributes skin care and wound care products | Direktor/Vorstandsmitglied | 29.07.2009 |
Witham Contract Manufacturing Ltd.
 Witham Contract Manufacturing Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical and healthcare products | Finanzdirektor/CFO | 24.10.2008 |
Microscience Ltd.
 Microscience Ltd. Pharmaceuticals: MajorHealth Technology Develops oral vaccines for typhoid, traveler's diarrhea, hepatitis B, and anthrax | Finanzdirektor/CFO | 27.06.2005 |
York Pharma Plc
 York Pharma Plc Pharmaceuticals: MajorHealth Technology Develops and markets dermatological products | Finanzdirektor/CFO | - |
Oxford Immunotec Ltd.
 Oxford Immunotec Ltd. Medical SpecialtiesHealth Technology Develops and sells medical diagnostic products | Finanzdirektor/CFO | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
16
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
York Pharma Plc
York Pharma Plc Pharmaceuticals: MajorHealth Technology Develops and markets dermatological products | Health Technology |
Microscience Ltd.
Microscience Ltd. Pharmaceuticals: MajorHealth Technology Develops oral vaccines for typhoid, traveler's diarrhea, hepatitis B, and anthrax | Health Technology |
Witham Contract Manufacturing Ltd.
Witham Contract Manufacturing Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical and healthcare products | Health Technology |
Oxford Immunotec Ltd.
Oxford Immunotec Ltd. Medical SpecialtiesHealth Technology Develops and sells medical diagnostic products | Health Technology |
Crawford Healthcare Ltd.
Crawford Healthcare Ltd. Medical DistributorsDistribution Services Distributes skin care and wound care products | Distribution Services |
Sixth Element Capital LLP
Sixth Element Capital LLP Investment ManagersFinance Sixth Element Capital invests in cancer and oncology drug discovery research projects across Europe. The firm provides financing for growth capital requirements with an investment up to £50 million. | Finance |
Adorx Therapeutics Ltd.
Adorx Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research of new therapeutics for cancer based on modulation of the adenosine pathway | Commercial Services |
Leucid Bio Ltd.
Leucid Bio Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biotech company that develops next generation CAR-T therapy | Commercial Services |
